Drugs Made In America Acquisition (DMAAR) Earnings (2024 - 2026)
Drugs Made In America Acquisition (DMAAR) earnings from Jun 30, 2024 to Mar 31, 2026. The TTM Drugs Made In America Acquisition (DMAAR) earnings is $6.65M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Drugs Made In America Acquisition (DMAAR) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +527.36% |
Annual Earnings change of Drugs Made In America Acquisition (DMAAR)
| Year | Earnings | Change |
|---|---|---|
| 2026 | $1.97M | -66.84% |
| 2025 | $5.94M | -3226.32% |
| 2024 | -$190K | N/A |